Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1+ Dendritic Cells Induces Potent Antitumoral Responses
Dorothea Terhorst‐Molawi, Even Fossum, Anna Barańska, et al.
The Journal of Immunology (2015) Vol. 194, Iss. 12, pp. 5895-5902
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Dendritic cell-based immunotherapy
Rachel Lubong Sabado, Sreekumar Balan, Nina Bhardwaj
Cell Research (2016) Vol. 27, Iss. 1, pp. 74-95
Open Access | Times Cited: 766
Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Jean-Charles Cancel, Karine Crozat, Marc Dalod, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 159
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
Björn E. Clausen, Patrizia Stoitzner
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 150
The role of dendritic cells in cancer
Yoke Seng Lee, Kristen J. Radford
International review of cell and molecular biology (2019), pp. 123-178
Closed Access | Times Cited: 133
Dexosomes as a cell-free vaccine for cancer immunotherapy
Sepideh Nikfarjam, Jafar Rezaie, Fatah Kashanchi, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 105
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
João Calmeiro, Mylène A. Carrascal, Adriana Ramos Tavares, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 158-158
Open Access | Times Cited: 95
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination
Virgil E.J.C. Schijns, Alberto Fernández‐Tejada, Žarko Barjaktarović, et al.
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 169-190
Open Access | Times Cited: 78
Targeting dendritic cells to advance cross-presentation and vaccination outcomes
Christophe Macri, Devi Jenika, Cassandra Ouslinis, et al.
Seminars in Immunology (2023) Vol. 68, pp. 101762-101762
Closed Access | Times Cited: 30
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Laser Therapy Inhibits Tumor Growth in Mice by Promoting Immune Surveillance and Vessel Normalization
Giulia Ottaviani, Valentina Martinelli, Katia Rupel, et al.
EBioMedicine (2016) Vol. 11, pp. 165-172
Open Access | Times Cited: 71
Therapeutic cancer vaccine: building the future from lessons of the past
Thi Tran, Charlotte Blanc, Clémence Granier, et al.
Seminars in Immunopathology (2018) Vol. 41, Iss. 1, pp. 69-85
Closed Access | Times Cited: 69
Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?
Sharan Bobbala, Sarah Hook
Pharmaceutical Research (2016) Vol. 33, Iss. 9, pp. 2078-2097
Closed Access | Times Cited: 65
Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets
Sanne Duinkerken, Sophie K. Horrevorts, Hakan Kalay, et al.
Theranostics (2019) Vol. 9, Iss. 20, pp. 5797-5809
Open Access | Times Cited: 58
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Annalisa Del Prete, Francesca Sozio, Ilaria Barbazza, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3930-3930
Open Access | Times Cited: 52
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets
Robin Reschke, Alexander Enk, Jessica C. Hassel
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6532-6532
Open Access | Times Cited: 8
Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines
Gunnveig Grødeland, Even Fossum, Bjarne Bogen
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 52
A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells
Kazuhiko Matsuo, Kosuke Kitahata, Fumika Kawabata, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 52
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
João Calmeiro, Mylène A. Carrascal, Célia Gomes, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 47
Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
Kazuhiko Matsuo, Osamu Yoshie, Kosuke Kitahata, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2495-2495
Open Access | Times Cited: 38
Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation
Sandra Scheiblhofer, Anna Strobl, Veronika Hoepflinger, et al.
Vaccine (2017) Vol. 35, Iss. 14, pp. 1802-1809
Closed Access | Times Cited: 42
Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9‐expressing conventional type‐1 dendritic cells
Momo Kamei, Kazuhiko Matsuo, Yusuke Yoshida, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 12, pp. 2176-2188
Closed Access | Times Cited: 4
Laser Therapy in the Oncology Patient
Chelsea D. Tripp, Lisa A. Miller
(2025), pp. 233-249
Closed Access
The multifaceted role of XCL1 in health and disease
M.A. Syed, Acacia F. Dishman, Brian F. Volkman, et al.
Protein Science (2025) Vol. 34, Iss. 2
Open Access
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma
Athanasios Seretis, Lukas Amon, Christoph H. Tripp, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 346-346
Open Access
Page 1 - Next Page

Scroll to top